Morpheus8 Treatment London

Morpheus8 combines microneedling and radiofrequency technologies to deliver effective results for a broad range of skin types, including darker tones. If you are experiencing signs of ageing, a consultation at one of Doctor Nyla’s clinics will help determine if Morpheus8 is suitable for you.

Morpheus8 is considered very safe for nearly all skin types and tones. Doctor Nyla and her team are highly trained and uphold exceptional standards to ensure the safety and well-being of all clients.

Morpheus8 is a minimally invasive procedure that most clients describe as involving minimal pain and discomfort. While microneedling does trigger a healing response, it can cause slight discomfort. To mitigate this, a numbing cream can be applied before treatment.

Post-treatment, the treated area may appear red and slightly swollen for up to three days, with potential itching. The consultation process will detail any other possible complications related to this procedure.

Typically, three treatments spaced 6-8 weeks apart are recommended for optimal results. The exact number and timing of sessions will vary depending on individual patient needs and goals.

Morpheus8 is primarily used on the lower face and neck to address wrinkles, skin laxity, discolouration, acne scarring, or stretch marks. However, it can be applied to most body areas where patients seek skin tightening.

Yes, Morpheus8 is highly effective. By combining microneedling and radiofrequency technology, it works well on all skin types, including darker tones that may not be suitable for other treatments.

For the first 24 hours post-treatment, it’s advised to avoid wearing make-up. Use only a gentle cleanser on your skin and apply moisturisers to alleviate dryness and tightness. Doctor Nyla’s team can recommend suitable products. Your skin might be sensitive to sunlight for a short period, so avoid sun exposure and apply a high SPF daily as part of your regular skincare routine.

Doctor Nyla’s London clinic is located in Mayfair, central London.